A Multicenter, Prospective, Observational, Post Marketing Surveillance Study to Evaluate the Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Patients With Chronic Hepatitis C Virus Infection in India
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 25 Aug 2017 Planned End Date changed from 1 Nov 2017 to 1 Apr 2018.
- 25 Aug 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Jan 2018.
- 25 Aug 2017 Status changed from recruiting to active, no longer recruiting.